Market Cap

Fennec Pharmaceuticals Inc. Market Capitalization:

$159.9 Million

USD as of July 1, 2024

business Fennec Pharmaceuticals Inc. Company Profile

Fennec Pharmaceuticals Inc. Main Stock Listing

NASDAQ: FENC

Market Capitalization History of Fennec Pharmaceuticals Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Fennec Pharmaceuticals Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $303.2 M 12.73%
Jan. 1, 2023 $268.9 M 113.33%
Jan. 1, 2022 $126.1 M -35.42%
Jan. 1, 2021 $195.2 M 8.11%
Jan. 1, 2020 $180.6 M -0.45%
Jan. 1, 2019 $181.4 M -24.41%
Jan. 1, 2018 $239.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Fennec Pharmaceuticals Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Fennec Pharmaceuticals Inc. has the following listings and related stock indices.


Stock: NASDAQ: FENC

Stock: TSX: FRX

Stock: FSX: RV41

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.